Terez, Marven D.

HRN: 24-89-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2024
CEFUROXIME 750MG (VIAL)
04/26/2024
05/03/2024
IV
750mg
Q8hrs
T/C Nasal Bone Fracture; T/C TBI
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: